Literature DB >> 16142854

The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).

Jean-Luc Senécal, Jill Hénault, Yves Raymond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16142854

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  14 in total

Review 1.  Functional autoantibodies in systemic sclerosis.

Authors:  Jeannine Günther; Judith Rademacher; Jakob M van Laar; Elise Siegert; Gabriela Riemekasten
Journal:  Semin Immunopathol       Date:  2015-08-21       Impact factor: 9.623

Review 2.  [Scleroderma associated autoantibodies - clinical and diagnostic relevance].

Authors:  R Mierau; E Genth
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

Review 3.  Assessing microvascular changes in systemic sclerosis diagnosis and management.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

Review 4.  Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis.

Authors:  Jean-Luc Senécal; Sabrina Hoa; Roger Yang; Martial Koenig
Journal:  J Scleroderma Relat Disord       Date:  2019-09-09

5.  Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population.

Authors:  J Wipff; Y Allanore; A Kahan; O Meyer; L Mouthon; L Guillevin; C Pierlot; E Glikmans; T Bardin; C Boileau; F Cornélis; P Dieudé
Journal:  Ann Rheum Dis       Date:  2006-02-07       Impact factor: 19.103

6.  Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis.

Authors:  Nina M van Leeuwen; Maaike Boonstra; Jaap A Bakker; Annette Grummels; Suzana Jordan; Sophie Liem; Oliver Distler; Anna-Maria Hoffmann-Vold; Karin Melsens; Vanessa Smith; Marie-Elise Truchetet; Hans U Scherer; René Toes; Tom W J Huizinga; Jeska K de Vries-Bouwstra
Journal:  Arthritis Rheumatol       Date:  2021-11-02       Impact factor: 15.483

Review 7.  Autoantibodies in systemic sclerosis: unanswered questions.

Authors:  Cristiane Kayser; Marvin J Fritzler
Journal:  Front Immunol       Date:  2015-04-15       Impact factor: 7.561

Review 8.  Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review.

Authors:  Mohammed A Omair; Abdulaziz Alahmadi; Sindhu R Johnson
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

9.  Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis.

Authors:  Elvira Favoino; Liboria Digiglio; Giovanna Cuomo; Isabella E Favia; Vito Racanelli; Gabriele Valentini; Federico Perosa
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

10.  Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.

Authors:  Federico Perosa; Elvira Favoino; Isabella Eleonora Favia; Serena Vettori; Marcella Prete; Addolorata Corrado; Francesco Paolo Cantatore; Gabriele Valentini
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.